INTENDED USE
One Step Multi-Drug Screen Test Cup is a rapid test for qualitative and simultaneous detection of Amphetamine, Barbiturates, Benzodiazepine, Buprenorphine, Cocaine, Fentanyl, Methamphetamine, Methadone, MDMA Ecstasy, Opiates, Oxycodone and Marijuana in human urine at the cutoff concentration of:
| Drug (Identifier) | Cut-off level (ng/ml) |
| Amphetamine(AMP) | 1,000 |
| Barbiturates(BARB) | 300 |
| Benzodiazepines(BZO) | 200 |
| Buprenorphine (BUP) | 10 |
| Cocaine (COC) | 300 |
| Fentanyl (FYL) | 10 |
| Methamphetamine (MET) | 500 |
| Methadone (MTD) | 300 |
| MDMA Ecstasy (MDMA) | 500 |
| Opiates (OPI) | 2,000 |
| Oxycodone (OXY) | 100 |
| Marijuana (THC) | 20 |
Configuration of the One Step Multi-Drug Screen Test Cup can consist of any combination of the above listed drug analytes.
The test provides only preliminary test results. A more specific alternative chemical method must be used in order to obtain a conformed analytical result. GC/MS is the preferred confirmatory method. Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary result is positive.
The test results can be used to provide evidence and basis for therapy and treatment plans of drug dependence and toxic psychosis. For laboratory professional in vitro diagnostic use only. The test should only be performed by health professionals in a clinical/hospital setting to aid in screening of drug of abuse to determine the follow-up treatment measures in combination of clinical symptoms.
